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Vascular cell biology is an area of research with great biomedical relevance. Vascular dysfunction is involved in major diseases such
as atherosclerosis, diabetes, and cancer. However, when studying vascular cell biology in the laboratory, it is difficult to mimic
the dynamic, three-dimensional microenvironment that is found in vivo. Microfluidic technology offers unique possibilities to
overcome this difficulty. In this review, an overview of the recent applications of microfluidic technology in the field of vascular
biological research will be given. Examples of how microfluidics can be used to generate shear stresses, growth factor gradients,
cocultures, and migration assays will be provided. The use of microfluidic devices in studying three-dimensional models of vascular
tissue will be discussed. It is concluded that microfluidic technology offers great possibilities to systematically study vascular cell
biology with setups that more closely mimic the in vivo situation than those that are generated with conventional methods.
Copyright © 2009 A. D. van der Meer et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
Vascular science is an active area of research. Scientists world-
wide are trying to unravel the mechanisms that determine
vascular function and dysfunction. Important objects of
study in this field of research include the maintenance of
vascular tone [1], regulation of inflammation [2], sprouting
of new blood vessels [3], regulation of cell survival [4],
and the differentiation of stem cells into vascular tissue
[5]. Vascular science is a field with a strong translational
focus, combining results from fundamental molecular and
cell biology with in vitro models of blood vessels and in
vivo tests to develop insight in vascular physiology and
treatment of disease. Vascular dysfunction is an important
factor in major diseases like atherosclerosis [6], cancer [7],
and diabetes [8]. The basis for understanding the functioning
of blood vessels lies in understanding its building blocks,
the vascular cells. Therefore, a lot of research is focused
on how endothelial cells or smooth muscle cells react
to relevant biological, chemical, or physical cues in vitro.
Usually, this work is carried out by using conventional
methods, culturing cells of animal or human origin in
wells-plates, subjecting them to the aforementioned stimuli,
and analyzing the outcome by biological or biochemical
techniques. However, in vivo dynamic conditions are present:
vascular endothelial cells are constantly subjected to shear
stress caused by the flowing blood [9], while smooth muscle
cells are stretched because of distension of the blood vessel
during the cardiac cycle [10]. Moreover, vascular cells are
embedded in a three-dimensional environment consisting
of an elastic extracellular matrix [11], other cells [12], and
flowing blood, with its platelets [13], red blood cells [14],
and leukocytes [15] (Figure 1). Both the three-dimensional
environment and the dynamic mechanical changes with each
cardiac cycle are very important factors in vascular cell
functioning. It is advantageous to design laboratory setups
that allow researchers to include these factors and control the
relevant parameters. The main challenge when building such
setups is that they should still be easy to assemble, handle,
and combine with conventional analysis techniques.
In the recent years, the field of microfluidic technol-
ogy has gained much scientific interest among biologists,
biochemists, and biophysicists (Figure 2). We feel that
microfluidic technology holds great promise to overcome
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Figure 1: Schematic overview of a blood vessel and the endothelial cell microenvironment. The inner wall of a blood vessel (left) consists of
a layer of endothelial cells that are embedded in a three-dimensional microenvironment (right). This environment consists of cell biological,
biochemical, and physical stimuli, such as red and white blood cells, signaling molecules, and shear stress, respectively. Mimicking this
complex microenvironment in vitro is a major challenge in vascular research.
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Figure 2: Graph of the amount of papers containing the keyword
“microfluidic” that were published per year as determined with
Google Scholar. A more than 30-fold increase in the yearly number
of scientific publications with this particular keyword can be
observed in the decade between 1995 and 2005.
the challenge of performing in vitro experiments with
more physiologically realistic setups that are still simple
enough to be used in everyday laboratory practice. Moreover,
microfluidic technology allows for increasing scale and paral-
lelization of current research, leading to more comprehensive
insights into cell and tissue physiology. The advantages of
microfluidic technology for cell culture in general have been
reviewed elsewhere [16, 17]. In this review, we will focus
specifically on the application of microfluidic devices in
vascular cell biology research.
2. Microfluidic Technology
2.1. Fabrication. Microfluidic technology deals with the
design, fabrication, and application of devices for manipu-
lation of fluids on the micrometer scale. Typically, the sizes
of features in these devices range from several micrometers
to a few hundred micrometers. The amounts of fluid that are
manipulated inside these devices are typically in the picoliter
to nanoliter range. Microfluidic devices can be fabricated
using metal, glass, or polymer materials. Most devices that
are used in combination with cell biological research are
made of glass or the silicone rubber polydimethylsiloxane
(PDMS), because these materials are cheap, biocompatible,
and transparent.
Because all microfluidic studies that are discussed in this
review use microfluidic devices of PDMS (sometimes com-
bined with glass components), the process of producing these
devices will be described shortly (see also Figure 3). PDMS
devices are produced by soft lithography replica molding
[18], which means that the devices are elastic replicas of
a stiff, reusable mold. The process starts by producing the
stiff mold with the desired structures. The mold is usually
made of silicon with micrometer-size structures produced
either by plasma-etching of the silicon plate or by building
on top of the plate with the epoxy-based, photo-crosslinkable
polymer SU-8. A mixture of PDMS oligomers is poured on
top of this mold, allowed to solidify by crosslinking, and
then peeled off from the mold. In order to create sealed
channels, the surface of the PDMS replica is activated with
oxygen plasma and bound to a PDMS or glass surface.
Holes can be punctured to reach the closed channel structure
and tubing can be connected to manipulate fluid inside the
channels. The silicon master-molds need to be produced in
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Figure 3: Schematic overview of the fabrication of PDMS chips.
(a) The process starts by fabricating a silicon master mold—
with typical dimensions of 10 centimeter in diameter and 0.5
millimeter thickness—with microfluidic structures on top. (b) A
viscous mixture of PDMS oligomers and crosslinker is poured on
top of the mold and allowed to form a flexible, crosslinked network.
(c) The slab of PDMS is peeled off of the mold and bound to a
glass or PDMS surface to produce closed microfluidic channels. (d)
The microfluidic device is ready to be used. Prior to binding to the
surface, holes can be punched in the slab of PDMS to reach the
resulting microfluidic channel.
a clean room, but replica molding can be performed under
standard laboratory conditions. Once the master-mold has
been created, producing new microfluidic devices by this
method takes only a few hours. Because the materials are
cheap, microfluidic devices can be discarded after every
experiment.
2.2. Cells and Microfluidic Technology. Generally speaking,
PDMS microfluidic devices offer a number of distinct
advantages over conventional techniques for cell culturing,
manipulation, and analysis. The main feature of microfluidic
devices that makes them suitable for use in cell biology is that
they are smaller than conventional setups (for an impression
of the size of a microfluidic channel, see Figure 4(a)). Because
of this small size, only limited amounts of cells, media, and
reagents are needed. This leads to a number of significant
benefits. First of all, if experiments are to be conducted
with rare primary cell material or expensive drugs, it is
quite advantageous to use only small quantities of these
valuable materials. Secondly, if cultures are to be maintained
under conditions of constant fluid flow, small sizes are
a considerable advantage. In conventional bioreactors, cell
culture medium is usually collected and re-used after it has
passed through the cell culture chamber. The medium is then
completely replaced every few days. In microfluidic devices,
a constant flux of fresh medium can be used, because the
volumes involved are orders of magnitude smaller. The third
benefit is that the small, planar and transparent microfluidic
setups are easily combined with bright field and fluorescence
microscopy or spectroscopy, because they fit easily on stages
of conventional microscopes. This facilitates monitoring
cell behavior for long periods and with high magnification
during the experiment.
It is important to realize that cells that are cultured
inside microfluidic devices need to be subjected to a constant
flux of fresh medium. When the small volumes in the cell-
containing devices would be left under static conditions,
nutrients would be depleted quickly, whereas waste products
would increase to undesirable concentrations. The fact
that constant refreshment of medium is needed may seem
cumbersome at first glance. However, under physiological
conditions, all cell types need a flux of nutrients and waste
products. The flow conditions in microfluidic devices mimic
this process more closely than in vitro culturing in wells
plates [19].
Because of the small dimensions of microfluidic chan-
nels, fluid flow is fully laminar, meaning that the flow
patterns are completely predictable and turbulent mixing
does not occur. In some applications, such as microreactors,
which require mixing of different reagents, this laminar flow
pattern is an obstacle that has to be overcome. However,
the laminar nature of the fluid flow can also be used to
perform unique experiments that are difficult or nearly
impossible to perform with conventional methods. Most of
these experiments rely on parallel fluid flows: if two streams
of fluid enter the chip in a parallel fashion, the two streams
will remain separated and mixing of them will only occur
by diffusion. Thus, the degree of mixing can be tuned by
changing the flow rate: the higher the flow rate, the shorter
the residence time inside the device, the less the streams mix.
Therefore, as long as flow rates are sufficiently high, cells on
one side of the device can be treated with one substance,
whereas cells on the other side are treated with another
substance. As a matter of fact, even two sides of a single cell
can be treated in this way [20].
Another important main feature of microfluidic technol-
ogy is that it is suitable for high-throughput, comprehensive
studies of cell biology. This means that the effect of multiple
factors and parameters on cell functioning can be screened in
one assay. Increasing throughput is an active area of research
in the field of microfluidics. Efforts are made to merge
microfluidic technology with microarray and microtitre
plate technology [21–23]. Also, researchers are dedicated to
integrate multiple steps, such as cell culturing, lysis, and
analysis in one device. Numerous examples of this parallel
and serial microfluidic biochemical analysis, also known as
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Figure 4: Endothelial cells in a microfluidic channel. (a) Human umbilical vein endothelial cells were cultured in a microfluidic channel.
When reaching confluence, the cells were fixated with paraformaldehyde and stained for actin filaments (green) and nuclei (blue). Scale
bar is 50 μm. (b) Endothelial cells that are subjected to physiological levels of shear stress inside microfluidic channels reorient their actin
cytoskeleton to align with the direction of fluid flow (right). Scale bars are 50 μm.
lab-on-a-chip, have already been reported and are starting to
be implemented in cell-containing microfluidic devices [16].
3. Microfluidic Technology and Vascular Cells
3.1. The Endothelial Mechanoresponse. Vascular endothelial
cells are highly responsive to shear stress that is caused by
the flow of fluid over their surface. This shear stress is the
result of the presence of a fluid velocity gradient in the cross
section of a tube. The velocity of the fluid next to the walls
is zero, whereas the velocity is maximal in the center of the
channel. The steeper this gradient, the higher the shear forces
that act on the vessel wall. The biological response to this
mechanical stimulus—the endothelial mechanoresponse—
has been found to be a key process in preventing vascular
disease [24]. The mechanoresponse is usually studied in vitro
by subjecting endothelial cells to shear stress in parallel plate
flow chambers. Microfluidic devices can be considered as
miniaturized versions of these setups. Because shear stress is
proportional to flow rate and inversely proportional to chan-
nel dimensions, only low flow rates are needed in microflu-
idic channels to mimic the high shear stresses found in the
human body. Song et al. [25] took advantage of this fact by
designing a microfluidic device that can subject endothelial
cells to physiological levels of shear stress in multiple parallel
channels. They showed that a flow rate of less than 200 μL
per hour is already enough to make the sheared endothelial
cells elongate and orient in the direction of the flow, which
is a prominent feature of the endothelial mechanoresponse
that is also found in vivo. This reorientation is also reflected
in the actin cytoskeleton of the cells. In our laboratory, we
subjected cells to a shear stress of 1 Pa for 12 hours and
then stained the actin filaments with phalloidin-FITC. Most
filaments were aligned and oriented in the flow direction
(Figure 4(b)). Recently, Tkachenko et al. [26] also reported
the design of a microfluidic device that allows for real-time
tracking of endothelial cells that are subjected to shear stress.
They could generate shear stresses ranging from 0.01 to 0.9
Pa in parallel channels, using flow rates in the range of several
milliliters per hour. In contrast, flow rates are in the order of
hundreds of milliliters per hour for the conventional, larger,
parallel plate flow chambers. Because of the small volumes
of reagents that are needed, and the potential parallelized
design of microfluidic devices, they are an ideal platform
for screening of compounds that may have an impact on
the mechanoresponse. We have recently developed such
an assay, in which the morphological rearrangements of
endothelial cells are used to quantify the mechanoresponse.
Using this assay, the impact of inhibitory drugs on the
mechanoresponse can be detected (paper submitted).
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Figure 5: Uses of parallel fluid flows inside microfluidic channels. (a) Parts of the microfluidic channel can be treated differently by pumping
two types of media into the two inlets. In this case, a fluorescent label was added to one of the parallel fluid streams. Flow is from bottom
to top; scale bar is 50 μm. (b) When flow rates are sufficiently low, media reside in the channel long enough for diffusion to take place.
This phenomenon can be used to generate and maintain steady gradients in a channel. In this case, three parallel inlet streams were used,
containing 0 μg/mL, 5 μg/mL, and 10 μg/mL dextran-rhodamine, respectively. When quantifying the fluorescence over the width of the
channel, an almost linear gradient can be observed (white square box in the image, plotted in the inset). (c) By using parallel flows, the
middle part of the channel was treated with trypsin. As a result, endothelial cells in the middle of the channel are selectively removed,
creating an artificial wound. The closing of this wound can be followed over time to quantify cell migration rates.
Another well-known effect of applying shear stress to
endothelial cells is the release of the vasodilatant, nitric oxide
[27]. Microfluidic assays have already been reported that can
detect the production of nitric oxide in response to chemical
stimuli amperometrically [28] or by fluorescence [29]. This
provides researchers with an interesting tool to study nitric
oxide release in response to both mechanical and chemical
stimuli.
When increasing the flow rate and the resultant shear
stress, microfluidic devices can also be used to study the
adhesion strength of endothelial cells to their underlying
substrate. Young et al. [30] performed such an experiment
with endothelial cells of different origins and two types of
matrix proteins. When the cells were subjected to a shear
stress that is about ten times higher than typical physiological
values, a certain percentage of cells detached from the sur-
face. In this manner, it was possible to give a semiquantitative
indication of the strength of adhesion of different cells on
different substrates. These types of experiments used to
be performed with large, parallel plate shear devices that
consumed large amounts of media, cells, and reagents [31].
Downscaling of these setups to micrometer dimensions is a
clear advantage.
3.2. Migration Assays. As discussed earlier, multiple parallel
fluid flows can be introduced in one microfluidic channel.
Transport of components from one flow to the other only
occurs by diffusion (Figure 5(a)). If flow rates are low,
there is sufficient time for the parallel streams to exchange
components. If one of the streams contains a drug or
active compound, stable gradients can be generated by
taking advantage of this diffusion. An example of such a
gradient that was produced in our laboratory is shown in
Figure 5(b). There are a number of studies that show how this
phenomenon can be used when experimenting with vascular
cells. Most of these studies focus on migration of vascular
cells in response to gradients of physical or biochemical cues.
Studying and understanding cell migration is important,
because it is a process involved in embryogenesis, wound
healing, and tumorigenesis.
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Barkefors et al. [32] studied migration of endothelial cells
in gradients of vascular endothelial growth factor (VEGF).
They designed a device with three inlets, generating three
parallel fluid streams in the main channel. When VEGF
was added to the middle stream, an increasing gradient
from the sides of the channel towards the middle was
generated. The steepness of this gradient could be tuned
by adjusting the flow rates: the slower the flow rate, the
longer the residence time in the channel, the more time there
is for VEGF to diffuse, and the more shallow the gradient
becomes. When endothelial cells were cultured in this stable
gradient of VEGF, they preferentially migrated towards the
middle of the channel. Because the researchers had control
over the shape of the gradient, they could show that steep
gradients induce faster migration. Moreover, it was found
that endothelial cells migrated fastest in gradients from 0
to 50 ng/mL, whereas they were not able to sense gradients
from 50 to 100 ng/mL due to saturation of the available
receptors.
Biochemical cues, such as the growth factors used in
this study, are not the only relevant stimuli for vascular cell
migration. In an elegant study, Zaari et al. [33] showed that
smooth muscle cells tend to migrate towards mechanically
stiffer underlying substrates. To reach this conclusion, the
authors designed a microfluidic device that could generate a
gradient of crosslinker, mixed with a solution of acrylamide.
A layer of gel with a gradient of stiffness was produced by
crosslinking the mixture with UV light into a polyacrylamide
network. When these gels were taken out of the microfluidic
devices and smooth muscle cells were seeded on them, all
cells tended to migrate towards the side of the gel with higher
stiffness.
Apart from migration assays that rely on gradients, the
parallel laminar fluid streams can also be used to bring the
most conventional migration assay to a microfluidic scale.
This assay is the scratch assay or wound healing assay. It
works by growing cells in a monolayer, artificially creating
a scratch and then following how this scratch is closed by
directed migration of the surrounding cells. In a microfluidic
device, the artificial scratch can be generated by adding the
serine protease trypsin to one of the parallel fluid streams.
When one side of the channel has been cleared of cells by
trypsinization, the migration of the remaining cells can be
followed over time to quantify directed migration. So far, this
assay has only been published with data on fibroblasts [34],
but work in our group has shown that it is also possible with
endothelial cells (Figure 5(c)). The advantage of carrying out
this assay in a microfluidic device is that it can be more easily
combined with stimuli such as shear stress or growth factor
gradients.
3.3. Cell Interactions. The principle of parallel streams is
not just useful in studies of cell migration. It can also be
used to pattern cells inside a microfluidic device. This is
important when interactions between cells are the object of
study. Micrometer-scale patterning of cells can be achieved
by stamping adhesive proteins on a substrate [35] or
by temporarily confining cells in a microfluidic device
until they adhere, after which the device is removed from
the surface [36]. By using parallel streams, cells can be
patterned without the need of removing the microfluidic
device afterwards. When adding one cell type to one
stream and another type to the parallel stream, cells can
be cocultured in direct contact with each other inside
a microfluidic device [37]. For vascular research, this
method could be used to pattern endothelial cells and
smooth muscle cells in one device. The planar nature of
microfluidic devices would provide great opportunities for
studying interactions between these cell types. In literature,
there are numerous reports of microfluidic setups that
are used for vascular cell interaction studies. For example,
Song et al. [38] studied the interaction between endothe-
lial cells and circulating tumor cells, a process that is
important for cancer metastasis. They developed a device
in which a layer of endothelial cells can be stimulated
with chemokines from the bottom, while being treated
simultaneously with a suspension of breast cancer cells
from the top. When the endothelium was stimulated with
CXCL12, a chemokine implicated in metastasis, they found
that more cancer cells adhered to the layer of endothelial
cells than under basal conditions. Another study on metas-
tasis used a microfluidic chip with small, gel-coated gaps,
overlaid with a monolayer of endothelial cells to mimic
the basement membrane and the endothelium, respectively
[39]. Using this microfluidic in vitro model of a blood
vessel, tumor cell migration could be quantified and studied
in great detail with time-lapse microscopy. It is not just
interactions between tumor cells and endothelium that
are an interesting object of research in vascular science.
Studying the interactions between other circulating cells
and endothelial cells is also important. For example, the
binding of leukocytes to endothelial cells is an essential
step in inflammation [40], while the endothelium-mediated
activation of blood platelets is important in clotting and
thrombosis [41]. Multiple reports have been published by
groups that studied the adhesion of leukocytes [42] or
platelets [43–45] to endothelial cells or endothelial cell-
derived adhesion factors in microfluidic devices. These
reports show that microfluidic cell interaction studies require
less sample and reagents than similar, conventional studies.
Moreover, a number of these studies already show increased
throughput by using parallel channels in one device [42, 44,
45].
3.4. Three-Dimensional Culturing. An important factor in
vascular cell physiology is its three-dimensional microen-
vironment. Cells are embedded in an environment that
comprises other cells, extracellular matrix proteins, bodily
fluids, and blood. Three-dimensional cell culturing in the
laboratory can be performed by incorporating cells in a
hydrogel matrix (e.g., the commercially available, collagen-
based Matrigel), or by growing cells on top of this matrix,
allowing them to migrate into the gel [46]. Still, the
complex real-life, three-dimensional microenvironment is
usually reduced to a two-dimensional system when exper-
iments are carried out on cells in vitro. This is more
convenient, because with such a system cells can easily be
supplied with fresh growth medium, growth factors, and
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Figure 6: Covering all surfaces of a microfluidic channel yields
“artificial capillaries.” Human endothelial cells were cultured in a
PDMS microfluidic channel and allowed to cover all surfaces. After
overnight culturing, cells were fixated and actin filaments were
imaged with confocal laser scanning microscopy. Top image is a
pseudocolored top view of the microfluidic channel. The red line
marks the section that was used to construct a front view of the
channel (middle image). The bottom image is an isometric volume
view of the same channel.
other soluble compounds. Moreover, a two-dimensional
setup is more compatible with microscopy and imaging.
However, when using microfluidic devices, replenishment of
medium, generation of gradients, and microscopic imaging
is relatively easy to realize in a three-dimensional culturing
environment. A good example is the recent publication by
Vickerman et al. [47] They describe a microfluidic device
with two parallel channels, connected by a gel chamber.
The gel chamber is filled with a collagen-based hydrogel
and endothelial cells are grown in one of the channels.
By generating a gradient of soluble growth factors, the
endothelial cells grow into the gel and even form open
capillaries that span the entire gel chamber from channel
to channel. In this particular article, the gel is pipetted
into the gel chamber by microinjection before assembling
the device. However, using the laminar flow properties
discussed earlier in this review, hydrogels can also be formed
in situ and even be patterned and confined to certain
regions of the microfluidic device [48]. The great potential
of these three-dimensional culturing techniques was recently
underlined by Barkefors et al. [49], who cultured ex vivo
kidney tissue and followed the formation of blood vessels
in response to a VEGF gradient. Because of the small scale
of microfluidic devices, it is possible to advance this proof-
of-concept study towards high-throughput assays in order
to screen for compounds that affect blood vessel formation
in such realistic models. A good example of this high-
throughput trend is the recent study by Hsiao et al. [50], who
studied three-dimensional, spheroid cocultures of prostate
cancer cells and endothelial cells in a microfluidic device
with 28 side chambers that could all harbor a tumorous
spheroid.
3.5. Compound Screening Assays. In biomedical engineering,
a lot of research is dedicated to developing particle systems
that carry drugs, proteins, DNA for gene therapy or siRNA
for gene silencing to their proper site of action. In this
field of research, it is important to have a way to quickly
screen for adhesion to endothelial cells—the first barrier that
particles encounter when injected intravenously. Screening
under static conditions in well plates ignores the mechanical
forces caused by the flowing blood, which counter particle
adhesion. A recent study by our group, using fluorescent
siRNA-containing polymer particles, shows that microfluidic
technology allows for quick screening of particle adhesion
to endothelial cells under dynamic conditions [51]. More
realistic microfluidic models of microvasculature have been
developed by Prabhakarpandian et al. [52] for the same
purposes. These devices contain channels that are designed
after real capillary networks. They show that capillary geom-
etry has a strong influence on local mechanical conditions
and particle adhesion. The fabrication of a more complex
microfluidic device that tries to mimic the tight blood-brain
barrier, while still being easy-to-use in high-throughput
assays, was recently reported by Genes et al. [53]. It is to
be expected that high-throughput screening in these more
realistic vascular models of the in vivo situation will become
the norm in drug development and material science in the
future.
3.6. Stem Cells and Tissue Engineering. Regenerative
medicine is the field in which researchers try to engineer
tissues in the laboratory to replace damaged or missing
tissue in the human body. It is a multi disciplinary
field, which combines materials science with cell biology
and biomedicine. A major challenge in this field is the
production of vascularized tissue for implantation. In order
to achieve this, stem cells must be stimulated to differentiate
into vascular cells, and these vascular cells need to arrange
themselves into a vascular network. Microfluidic technology
can be of use in both processes. For differentiation of
human stem cells to vascular tissue, many factors can be
of influence. Because human stem cells and the inducing
factors are relatively difficult to obtain, it is advantageous
to perform tests in a microfluidic setting instead of in a
macroscopic assay. Figallo et al. [54] developed a 12-well
micro-bioreactor in which human embryonic stem cells
were directed towards a vascular phenotype by varying
growth factors, perfusion, and cell seeding density. Using
such microfluidic devices instead of conventional techniques
saves reagents and allows for more flexibility in terms of
culture parameters.
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The other aspect of vascular tissue engineering in which
microfluidic technology can be of help is in preparing
vascular networks that can be incorporated into tissue
constructs. This can be accomplished by two approaches.
First of all, a “synthetic capillary” can be engineered by
using microfluidic technology. This works by designing
a microfluidic channel of which the walls contain tiny
gaps of only a few micrometer in diameter and tens of
micrometers in length. Behind these gaps, compartments
are located in which tissue can be grown. When medium
is pumped through the channel, the gaps act as a simple
endothelium-like barrier, limiting mass transport to the
tissue compartments. An example of such a microfluidic
design was reported by Lee et al. [55], who used this
principle to design synthetic analogs of liver sinusoids. Using
this approach, mass transport over the endothelium-like
barrier can be tweaked to mimic the values found in human
vessels [56, 57]. A second approach to use microfluidic
technology for generation of vascular networks is based
on the notion that the microfluidic device itself can be
considered as a three-dimensional “scaffold” in which cells
can be grown. When all sides of a channel are completely
covered with endothelial cells, microvascular networks are
generated that mimic in vivo networks (Figure 6). It has
been shown that this approach will in principle work:
PDMS devices with microvascular network morphologies
can be completely covered with endothelial cells to generate
capillary-like structures [58]. However, PDMS is a non-
biodegradable polymer. Biodegradability is paramount if
eventually the material is to be replaced with functional
tissue. Another study has shown that the same type of
system can also be built with the biodegradable poly-
mer poly (glycerol sebacate) [59]. Still, these microfluidic
devices consist of only one flat layer of vascular struc-
tures. A major challenge will be to build biodegradable,
truly three-dimensional microvascular networks that can
be combined with other materials and cells in regenerative
medicine. Novel rapid techniques for three-dimensional
device fabrication, such as stereolithography with biodegrad-
able polymers [60], hold great promise to overcome this
challenge.
4. Conclusion
The examples given in this review clearly illustrate the fact
that the use of microfluidic technology facilitates current
vascular research and, more importantly, opens up novel
areas of research that are not possible with more conven-
tional setups and techniques. It is important to realize not
only that microfluidic technology paves the way for more
realistic in vitro models in vascular cell biology but also that
the technology is still in its infancy in terms of throughput.
Almost all studies described in this review are proof-of-
principle experiments that require a lot of personal effort
and intervention by the researcher. However, automation,
standardization, and increasing scale will all be natural
stages in the maturation of microfluidic technology. These
improvements will boost the systematic nature of vascular
cell biological research in the future.
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